The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology, cilt.30, ss.505-510, 2019 (SCI-Expanded)
Background/Aims: Using proton-pump inhibitor (PPI) is a protective option for patients who require long-term non-steroidal anti-inflammatory drugs (NSAIDs) and antiaggregants. In our previous study, the rate of PPI use in prophylaxis was found to be 2%. Here we aimed to investigate whether there is a change in PPI use in prophylaxis in a similar patient group after 10 years.